Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Versant Venture Capital III, L.P. Insider Profile
4 Followers
Versant Venture Capital III, L.P., Ten Percent Owner at Ocular Therapeutix, holds 2.22M shares in Ocular Therapeutix (Ticker: OCUL), holds 2.25K shares in Flexion Therapeutics (Ticker: FLXN), holds 1.97M shares in Immune Design (Ticker: IMDZ). Most recently, Versant Venture Capital III, L.P. Sold ― shares of Ocular Therapeutix on Jun 15, 2015 for an estimated value of 7.04M.
Versant Venture Capital III, L.P. Ocular Therapeutix (OCUL)Ten Percent Owner
Ocular Therapeutix (OCUL)
Ten Percent Owner
Ranked #3,757 out of 73,699 Corporate Insiders
Profitable Transactions
6 out of 6 Profitable Transactions
Average Return
+46.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Versant Venture Capital III, L.P. holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jun 15, 2015 - Jun 15, 2016
Return:+74.20%
The most profitable trade made by Versant Venture Capital III, L.P.
Versant Venture Capital III, L.P.'s Trading History
Ocular Therapeutix
Jun 15, 2015
Ten Percent Owner
Informative Sell
7.04M
$42.22M
Immune Design
Jul 31, 2014
―
Uninformative Buy
2.50M
$27.65M
Flexion Therapeutics
Sep 12, 2014
Director, Ten Percent Owner
Informative Buy
39.62K
$49.59K
Trius Therap
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Versant Venture Capital III, L.P.'s performance on stock
You May Also Like
Versant Venture Capital III, L.P. insider profile FAQ
What is the percentage of profitable transactions made by Versant Venture Capital III, L.P.?
The percentage of profitable transactions made by Versant Venture Capital III, L.P. is 100%.
What is the average return per transaction made by Versant Venture Capital III, L.P.?
The average return per transaction made by Versant Venture Capital III, L.P. is 46.30%.
What stocks does Versant Venture Capital III, L.P. hold?
Versant Venture Capital III, L.P. holds: OCUL, IMDZ, FLXN, TSRX stocks.
What was Versant Venture Capital III, L.P.’s latest transaction?
Versant Venture Capital III, L.P. latest transaction was an Informative Sell of 7.04M.
What was Versant Venture Capital III, L.P.'s most profitable transaction?
Versant Venture Capital III, L.P.’s most profitable transaction was an Informative Sell of OCUL stock on June 15, 2015. The return on the trade was 74.20%.
What is Versant Venture Capital III, L.P.'s role in Ocular Therapeutix?
Versant Venture Capital III, L.P.'s role in Ocular Therapeutix is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.